Zhong X - Search Results

1

MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.

Zhong X, Xie G, Zhang Z, Wang Z, Wang Y, Wang Y, Qiu Y, Li L, Bu H, Li J, Zheng H. Zhong X, et al. Oncotarget. 2016 Sep 20;7(38):61166-61182. doi: 10.18632/oncotarget.11278. Oncotarget. 2016. PMID: 27533459 Free PMC article.

2

[Primary experimental results of methylseleninic acid on the proliferation inhibition and apoptotic induction in human high-metastatic large cell lung cancer cell line L9981].

Liu J, Zhong X, Zhou Q, Gao AC, Wang Y, Zhu W, Ma L, Zhang Z. Liu J, et al. Among authors: zhong x. Zhongguo Fei Ai Za Zhi. 2006 Apr 20;9(2):103-8. doi: 10.3779/j.issn.1009-3419.2006.02.01. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21144291 Free article. Chinese.

3

Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a Chinese population.

Luo T, Chen L, He P, Hu QC, Zhong XR, Sun Y, Yang YF, Tian TL, Zheng H. Luo T, et al. Asian Pac J Cancer Prev. 2013;14(4):2433-7. doi: 10.7314/apjcp.2013.14.4.2433. Asian Pac J Cancer Prev. 2013. PMID: 23725153 Free article.

4

[New challenges of personalized therapy for breast cancer to pathologists].

Zhong X, Luo T, Zheng H, Bu H. Zhong X, et al. Zhonghua Bing Li Xue Za Zhi. 2014 Apr;43(4):219-21. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 24915809 Chinese. No abstract available.

5

Trends and present treatment patterns of early breast cancer in Southwest China.

Hu Q, Luo T, He P, Zhong X, Tian T, Lv Q, Yan X, Zheng H. Hu Q, et al. Among authors: zhong x. Pathol Oncol Res. 2015 Apr;21(2):367-78. doi: 10.1007/s12253-014-9829-z. Epub 2014 Aug 6. Pathol Oncol Res. 2015. PMID: 25096396 Free article.

6

Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective study.

Liu M, Yang YJ, Zheng H, Zhong XR, Wang Y, Wang Z, Wang YG, Wang YP. Liu M, et al. Oncol Rep. 2014 Dec;32(6):2619-27. doi: 10.3892/or.2014.3496. Epub 2014 Sep 18. Oncol Rep. 2014. PMID: 25241923

7

Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.

Deng L, Chen J, Zhong XR, Luo T, Wang YP, Huang HF, Yin LJ, Qiu Y, Bu H, Lv Q, Zheng H. Deng L, et al. PLoS One. 2015 Mar 27;10(3):e0120511. doi: 10.1371/journal.pone.0120511. eCollection 2015. PLoS One. 2015. PMID: 25816324 Free PMC article.

8

Application status of tamoxifen in endocrine therapy for early breast cancer.

Hu Q, Luo T, Zhong X, He P, Tian T, Zheng H. Hu Q, et al. Among authors: zhong x. Exp Ther Med. 2015 Jun;9(6):2207-2212. doi: 10.3892/etm.2015.2437. Epub 2015 Apr 20. Exp Ther Med. 2015. PMID: 26136961 Free PMC article.

9

The Impact of Different Preservation Conditions and Freezing-Thawing Cycles on Quality of RNA, DNA, and Proteins in Cancer Tissue.

Wang Y, Zheng H, Chen J, Zhong X, Wang Y, Wang Z, Wang Y. Wang Y, et al. Among authors: zhong x. Biopreserv Biobank. 2015 Oct;13(5):335-47. doi: 10.1089/bio.2015.0029. Biopreserv Biobank. 2015. PMID: 26484573

10

ALDH(+)/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcome.

Qiu Y, Pu T, Guo P, Wei B, Zhang Z, Zhang H, Zhong X, Zheng H, Chen L, Bu H, Ye F. Qiu Y, et al. Among authors: zhong x. Exp Mol Pathol. 2016 Feb;100(1):145-50. doi: 10.1016/j.yexmp.2015.11.032. Epub 2015 Dec 11. Exp Mol Pathol. 2016. PMID: 26687806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,546 results

Search Page

Filters